Methylergobasine
Brand names,
Methylergobasine
Analogs
Methylergobasine
Brand Names Mixture
Methylergobasine
Chemical_Formula
C20H25N3O2
Methylergobasine
RX_link
http://www.rxlist.com/cgi/generic2/methylerg.htm
Methylergobasine
fda sheet
Methylergobasine
msds (material safety sheet)
Methylergobasine
Synthesis Reference
A. Stoll et al., eidem, Helv. Chim. Acta. 26, 944 (1943)
Methylergobasine
Molecular Weight
339.432 g/mol
Methylergobasine
Melting Point
172 oC
Methylergobasine
H2O Solubility
25 mg/mL
Methylergobasine
State
Solid
Methylergobasine
LogP
1.01
Methylergobasine
Dosage Forms
Injection (intramuscular or intravenous); Tablet
Methylergobasine
Indication
For the prevention and control of excessive bleeding following vaginal childbirth
Methylergobasine
Pharmacology
Methylergonovine is a semisynthetic ergot alkaloid and a derivative of ergonovine and is used for the prevention and control of postpartum and post-abortion hemorrhage. In general, the effects of all the ergot alkaloids appear to results from their actions as partial agonists or antagonists at adrenergic, dopaminergic, and tryptaminergic receptors. The spectrum of effects depends on the agent, dosage, species, tissue, and experimental or physiological conditions. All of the alkaloids of ergot significantly increase the motor activity of the uterus. After small doses contractions are increased in force or frequency, or both, but are followed by a normal degree of relaxation. As the dose is increased, contractions become more forceful and prolonged, resting tonus is markedly increased, and sustained contracture can result.
Methylergobasine
Absorption
Absorption is rapid after oral (60% bioavailability) and intramuscular (78% bioavailability) administration.
Methylergobasine
side effects and Toxicity
Signs and symptoms of overexposure: hypertension, seizures, headache, hypotension, nausea, and vomiting.
Methylergobasine
Patient Information
Methylergobasine
Organisms Affected
Humans and other mammals